MYC and diffuse large B-cell lymphoma: JQ1, the first small molecule bromodomain inhibitor, caused the down-regulation of the c-Myc transcription and c-Myc-dependent target genes in acute myeloid leukemia, Burkitt lymphoma and diffuse large B-cell lymphoma [29, 30].